NaV1.1 and NaV1.6 selective compounds reduce the behavior phenotype in a novel zebrafish model for Dravet Syndrome
Wout J. Weuring(Utrecht University), Bobby P.C. Koeleman(University Medical Center Utrecht), Marco Inserra(The University of Queensland), Sakshi Singh(National Institutes of Health), Mirko Rivara(University of Parma), Linda Volkers(Centre National de la Recherche Scientifique), Martin B. Rook(University Medical Center Utrecht), Nanda M. Verhoeven‐Duif(University Medical Center Utrecht), Kees P. J. Braun(University Medical Center Utrecht), Ruben H. van ’t Slot(Utrecht University), Marjolein Bosma(Utrecht University), Irina Vetter(Centre National de la Recherche Scientifique)
Cited by 6
Related Papers
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
|Nature Medicine|2015|2.8k
Methods Used to Evaluate Pain Behaviors in Rodents
|Frontiers in Molecular Neuroscience|2017|1.3k
Histopathological Findings in Brain Tissue Obtained during Epilepsy Surgery
|New England Journal of Medicine|2017|916
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
|Frontiers in Molecular Neuroscience|2017|654
Conus Venom Peptide Pharmacology
|Pharmacological Reviews|2012|422